AlphaCentric LifeSci Healthcare Fund Class C (LYFCX) Forecast
See the Price Targets and Ratings of:
LYFCX Analyst Rating
Strong Buy
61ConsensusRatings
51Buy10Hold0Sell
Based on the Wall Street analyst consensus for 61 of LYFCX’s holdings.
LYFCX Analyst Price Target
Average Price Target
$25.44▲(44.28% Upside)
Based on Wall Street analyst 12-month price targets for 61 of AlphaCentric LifeSci Healthcare Fund Class C’s holdings in the last 3 months. The average price target is $25.44 with a high forecast of $32.01 and a low forecast of $18.79. The average price target represents a 44.28% change from the last price of $17.63.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$32.01
Average$25.44
Low$18.79
Past 12 Months12 Month Forecast$13$18$23$28$33Feb2026May2026Aug2026Nov2026Nov2027
What is LYFCX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 61 of LYFCX’s holdings, AlphaCentric LifeSci Healthcare Fund Class C’s 12-month average price target is $25.44.
What is LYFCX’s upside potential, based on the analysts’ average price target?
LYFCX’s average price target of $25.44 represents a 44.28% upside from its last price of $17.63.
Is LYFCX a Buy, Sell or Hold?
AlphaCentric LifeSci Healthcare Fund Class C has a consensus rating of Strong Buy, based on the analyst consensus for 61 of LYFCX’s holdings: 51 rated Buy, 10 rated Hold and 0 rated Sell.
What is AlphaCentric LifeSci Healthcare Fund Class C’s price target?
The average price target for AlphaCentric LifeSci Healthcare Fund Class C is $25.44, based on Wall Street analyst 12-month price targets for 61 of LYFCX’s holdings, issued in the past 3 months. The highest price target is $32.01 and the lowest is $18.79. The average price target represents a 44.28% increase from the last price of $17.63.
How can I buy shares of LYFCX?
You can buy shares of LYFCX through a brokerage account. Compare brokers on our Best Online Brokers page.